Cramer says investors shouldn’t fear market declines and instead look for buying opportunities

Cramer says investors shouldn’t fear market declines and instead look for buying opportunities


CNBC’s Jim Cramer on Tuesday said that investors shouldn’t fear the market’s declines now that interest rates are coming down since that means there are buying opportunities.

“You can’t have it both ways. You can’t be scared of higher rates and lower rates. History says we should like lower interest rates. … And, of course, it’s a sign that the Fed is winning its war against inflation after a couple of aggressive rate hikes,” the “Mad Money” host said.

“So should we hate this market or learn to love it? Wrong question. Perhaps, we should like the stocks that now sell at historically, even record-breaking low valuations,” he added.

U.S. stocks concluded a rough end to the first half of the year in June. The benchmark 10-year Treasury yield and the two-year yield inverted on Tuesday — a sign that historically indicates a recession is looming. When short-term Treasury yields are above long-term yields, it suggests that investors believe an economic slowdown will result in interest rate cuts.

Tech stocks rose on Tuesday while stocks associated with economic growth fell. Oil also tumbled, with the U.S. benchmark West Texas Intermediate dropping below $100 a barrel. 

Cramer said that instead of bemoaning the market’s downturn, investors should see it as a buying opportunity.

“We can’t act like there have been no declines. … In fact, with the collapse of the oils, there’s no group left that hasn’t been savaged,” he said. “That may be enough to justify thinking more positively about this entire now-despised asset class, too. Funny thing about stocks — they do still get cheaper as they go lower.”



Source

FDA fast-tracks psychedelic drug research following Trump executive order
Business

FDA fast-tracks psychedelic drug research following Trump executive order

FILE PHOTO: Psilocybin or “magic mushrooms” are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA) in Washington, U.S. May 7, 2019. DEA | Reuters The U.S. Food and Drug Administration on Friday announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness. That […]

Read More
New York’s pied-a-terre tax sets up legal fight over values
Business

New York’s pied-a-terre tax sets up legal fight over values

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. New York’s proposed tax on second homes worth more than $5 million is likely to spark costly legal battles over how to value […]

Read More
Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More